---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-005351"
form_type: "8-K"
ticker: "ESPR"
cik: "0001434868"
company_name: "Esperion Therapeutics, Inc."
filed_at: "2024-01-22T23:59:59+00:00"
generated_at: "2026-06-06T20:35:00.898826+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Esperion prices $85.1M public offering of 56.7M shares at $1.50; underwriters fully exercise option

## Summary
- Offering of 56,700,000 shares priced at $1.50 per share; gross proceeds ~$85.1M.
- Underwriters fully exercised option for additional 8,505,000 shares at same price.
- Net proceeds expected to be ~$90.8M after underwriting discount and expenses.
- Closing expected Jan 23, 2024; Jefferies LLC sole book-running manager.
- Proceeds to fund commercialization of NEXLETOL/NEXLIZET, R&D, and working capital.

## SEC filing metadata
- accession: 0001104659-24-005351
- form_type: 8-K
- ticker: ESPR
- cik: 0001434868
- company_name: Esperion Therapeutics, Inc.
- filed_at: 2024-01-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434868/000110465924005351/0001104659-24-005351-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434868/000110465924005351/tm243774d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-005351
- JSON: https://secwatch.observer/filing/0001104659-24-005351.json
- Plain text: https://secwatch.observer/filing/0001104659-24-005351.txt

## Key facts
- Material Agreements
  Esperion Therapeutics, Inc. entered into Underwriting Agreement with Jefferies LLC (effective 2024-01-18).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Jefferies LLC
  - Effective: 2024-01-18
  source text: On January 18, 2024, Esperion Therapeutics, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Jefferies LLC (“Jefferies”), as representative of the several underwriters listed on Schedule A thereto (the “Underwriters”), related to an underwritten public offering (the “Offering”) of 56,700,000 shares of common stock of the Company, par value $0.001 per share (“Common Stock”), at a purchase price to the public of $1.50 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1434868/000110465924005351/0001104659-24-005351-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.